Allergy Therapeutics
AGY.L
#7195
Rank
NZ$0.73 B
Marketcap
$0.15
Share price
7.69%
Change (1 day)
215.24%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2023: -NZ$93.45 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$75.16 Million. In 2023 the company made an earning of -NZ$93.45 Million a decrease over its 2022 earnings that were of -NZ$27.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2023

Annual earnings

Year Earnings Change
2023-NZ$93.45 Million243.12%
2022-NZ$27.24 Million-403.33%
2021NZ$8.97 M-49.05%
2020NZ$17.62 M82.31%
2019NZ$9.66 M-159.83%
2018-NZ$16.16 Million255.37%
2017-NZ$4.55 Million-84.22%
2016-NZ$28.82 Million-1678.94%
2015NZ$1.82 M-44.28%
2014NZ$3.27 M129.45%
2013NZ$1.42 M-19.85%
2012NZ$1.78 M-127%
2011-NZ$6.6 Million2044.94%
2010-NZ$0.31 Million-99.08%
2009-NZ$33.41 Million-53.32%
2008-NZ$71.57 Million-21.76%
2007-NZ$91.47 Million351.81%
2006-NZ$20.25 Million230.51%
2005-NZ$6.13 Million-219.33%
2004NZ$5.13 M-58.79%
2003NZ$12.45 M-196.03%
2002-NZ$12.98 Million